Symbols / NBY $1.95 +22.64% NovaBay Pharmaceuticals, Inc.
NBY Chart
About
NovaBay Pharmaceuticals, Inc. engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol. Its services intend to support protocol-level services, including staking, governance participation, validation, and related activities. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 51.92M |
| Enterprise Value | 45.09M | Income | -33.22M | Sales | — |
| Book/sh | -0.92 | Cash/sh | 0.30 | Dividend Yield | — |
| Payout | 0.00% | Employees | 2 | IPO | — |
| P/E | 0.05 | Forward P/E | -2.38 | PEG | — |
| P/S | — | P/B | -2.12 | P/C | — |
| EV/EBITDA | -5.95 | EV/Sales | — | Quick Ratio | 6.97 |
| Current Ratio | 7.60 | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | -28.50 | EPS next Y | -0.82 | EPS Growth | — |
| Revenue Growth | — | Earnings | 2025-08-12 15:00 | ROA | -76.11% |
| ROE | — | ROIC | — | Gross Margin | 0.00% |
| Oper. Margin | 3.50% | Profit Margin | 0.00% | Shs Outstand | 26.63M |
| Shs Float | 2.62M | Short Float | 9.79% | Short Ratio | 0.69 |
| Short Interest | — | 52W High | 99.75 | 52W Low | 1.11 |
| Beta | 0.16 | Avg Volume | 558.02K | Volume | 626.37K |
| Target Price | — | Recom | None | Prev Close | $1.59 |
| Price | $1.95 | Change | 22.64% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2024-11-11 | main | Ascendiant Capital | Buy → Buy | $1 |
| 2023-08-11 | main | Ladenburg Thalmann | Buy → Buy | $4 |
News
RSS: Latest NBY news- Assessing NovaBay Pharmaceuticals’ (NBY) Valuation After A Sharp Short Term Share Price Surge - finance.yahoo.com Sun, 11 Jan 2026 08
- After $134M deal, NovaBay rebrands around 2.06B SKY tokens - Stock Titan Mon, 23 Mar 2026 07
- Why NovaBay Pharmaceuticals (NBY) Is Up 99.3% After Pivoting From Liquidation To Restructuring And Asset Sales - simplywall.st ue, 13 Jan 2026 08
- NovaBay Pharmaceuticals stock falls after $100 million ATM offering - Investing.com ue, 20 Jan 2026 08
- NovaBay Pharmaceuticals, Inc. (NBY) Stock Price Today & Analysis - Gotrade ue, 13 Jan 2026 00
- NovaBay falls on deal for $100M stock (update) (NBY:NYSE) - Seeking Alpha ue, 20 Jan 2026 08
- NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Stock Price Up 14.2% - Should You Buy? - MarketBeat Mon, 05 Jan 2026 08
- NovaBay Pharma Rebrands as Stablecoin Development Corporation - TipRanks Wed, 01 Apr 2026 21
- Stablecoin Development (NBY) director awarded 140,000 restricted stock units - Stock Titan hu, 02 Apr 2026 20
- NBY Stock Up 100%: What Just Happened to NovaBay Stock? - EBC Financial Group Mon, 12 Jan 2026 08
- NovaBay Pharmaceuticals, Inc. will Change its Ticker to SDEV from NBY - marketscreener.com Fri, 03 Apr 2026 01
- NovaBay Pharmaceuticals (NBY) Stock: Rebrands as Stablecoin Development Corp, Acquires $147M in SKY Tokens - CoinCentral Mon, 23 Mar 2026 15
- NovaBay Pharmaceuticals, Inc. (NBY) Declares $0.80 Special Dividend, Boosting Shareholder Value - finance.yahoo.com ue, 23 Sep 2025 07
- Novabay Pharmaceuticals stock hits 52-week high at 11.49 USD - Investing.com Fri, 09 Jan 2026 08
- Stablecoin Development Corp (SDEV) CEO receives large time- and performance-based RSU grants - Stock Titan Fri, 03 Apr 2026 02
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
-100.00%
|
10.46
-27.42%
|
14.40
|
| Operating Revenue |
|
0.00
|
0.00
-100.00%
|
10.46
-27.26%
|
14.37
|
| Cost Of Revenue |
|
—
|
3.30
-24.50%
|
4.37
-34.00%
|
6.62
|
| Reconciled Cost Of Revenue |
|
—
|
3.30
-24.50%
|
4.37
-34.00%
|
6.62
|
| Gross Profit |
|
—
|
6.48
+6.53%
|
6.08
-21.81%
|
7.78
|
| Operating Expense |
|
7.58
+2.79%
|
7.38
-27.56%
|
10.19
-34.12%
|
15.46
|
| Research And Development |
|
—
|
0.04
+23.53%
|
0.03
-80.46%
|
0.17
|
| Selling General And Administration |
|
7.58
+2.79%
|
7.38
-27.31%
|
10.15
-33.59%
|
15.29
|
| Selling And Marketing Expense |
|
—
|
4.03
-14.26%
|
4.71
-39.66%
|
7.80
|
| General And Administrative Expense |
|
7.58
+2.79%
|
7.38
+35.47%
|
5.45
-27.27%
|
7.49
|
| Other Gand A |
|
7.58
+2.79%
|
7.38
+35.47%
|
5.45
-27.27%
|
7.49
|
| Total Expenses |
|
7.58
+2.79%
|
7.38
-49.31%
|
14.56
-34.08%
|
22.08
|
| Operating Income |
|
-7.58
-2.79%
|
-7.38
-79.89%
|
-4.10
+46.59%
|
-7.68
|
| Total Operating Income As Reported |
|
-8.44
-14.37%
|
-7.38
-79.89%
|
-4.10
+71.55%
|
-14.42
|
| EBITDA |
|
-32.80
-337.11%
|
-7.50
-83.27%
|
-4.09
+43.10%
|
-7.20
|
| Normalized EBITDA |
|
-7.46
+2.02%
|
-7.62
-72.88%
|
-4.41
+3.04%
|
-4.54
|
| Reconciled Depreciation |
|
0.14
-58.94%
|
0.34
-4.21%
|
0.36
-26.29%
|
0.48
|
| EBIT |
|
-32.95
-319.90%
|
-7.85
-76.27%
|
-4.45
+42.04%
|
-7.68
|
| Total Unusual Items |
|
-25.34
-22328.07%
|
0.11
-63.46%
|
0.31
+111.76%
|
-2.65
|
| Total Unusual Items Excluding Goodwill |
|
-25.34
-22328.07%
|
0.11
-63.46%
|
0.31
+111.76%
|
-2.65
|
| Special Income Charges |
|
-0.85
|
0.00
|
0.00
+100.00%
|
-6.18
|
| Other Special Charges |
|
—
|
0.01
|
—
|
—
|
| Impairment Of Capital Assets |
|
0.85
|
0.00
-100.00%
|
2.59
-61.51%
|
6.74
|
| Restructuring And Mergern Acquisition |
|
—
|
—
|
0.00
+100.00%
|
-0.56
|
| Net Income |
|
-22.14
-206.53%
|
-7.22
+25.07%
|
-9.64
+9.13%
|
-10.61
|
| Pretax Income |
|
-33.22
-279.68%
|
-8.75
-42.39%
|
-6.14
+42.07%
|
-10.61
|
| Net Non Operating Interest Income Expense |
|
-0.28
+69.36%
|
-0.90
+46.64%
|
-1.69
|
—
|
| Interest Expense Non Operating |
|
0.28
-69.36%
|
0.90
-46.64%
|
1.69
|
—
|
| Net Interest Income |
|
-0.28
+69.36%
|
-0.90
+46.64%
|
-1.69
|
—
|
| Interest Expense |
|
0.28
-69.36%
|
0.90
-46.64%
|
1.69
|
—
|
| Other Income Expense |
|
-25.36
-5330.41%
|
-0.47
-33.81%
|
-0.35
+88.08%
|
-2.93
|
| Other Non Operating Income Expenses |
|
-0.02
+96.56%
|
-0.58
+12.10%
|
-0.66
-139.49%
|
-0.28
|
| Gain On Sale Of Security |
|
-24.49
-21578.95%
|
0.11
-63.46%
|
0.31
-91.15%
|
3.52
|
| Gain On Sale Of Business |
|
—
|
-0.86
|
0.00
|
—
|
| Tax Provision |
|
—
|
—
|
—
|
—
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-22.14
-206.53%
|
-7.22
+25.07%
|
-9.64
+9.13%
|
-10.61
|
| Net Income From Continuing Operation Net Minority Interest |
|
-33.22
-279.68%
|
-8.75
-42.39%
|
-6.14
+42.07%
|
-10.61
|
| Net Income From Continuing And Discontinued Operation |
|
-22.14
-206.53%
|
-7.22
+25.07%
|
-9.64
+9.13%
|
-10.61
|
| Net Income Continuous Operations |
|
-33.22
-279.68%
|
-8.75
-42.39%
|
-6.14
+42.07%
|
-10.61
|
| Net Income Discontinuous Operations |
|
11.08
+625.67%
|
1.53
+143.69%
|
-3.50
|
—
|
| Normalized Income |
|
-7.88
+11.08%
|
-8.86
-37.28%
|
-6.46
+18.84%
|
-7.96
|
| Net Income Common Stockholders |
|
-22.14
-157.21%
|
-8.61
+48.45%
|
-16.70
-2.66%
|
-16.27
|
| Otherunder Preferred Stock Dividend |
|
0.00
-100.00%
|
1.39
-80.37%
|
7.06
+24.75%
|
5.66
|
| Diluted EPS |
|
-19.00
-49.84%
|
-12.68
+98.18%
|
-695.70
+60.64%
|
-1,767.50
|
| Basic EPS |
|
-19.00
-49.84%
|
-12.68
+98.18%
|
-695.70
+60.64%
|
-1,767.50
|
| Basic Average Shares |
|
1.16
+71.43%
|
0.68
+2729.17%
|
0.02
+160.87%
|
0.01
|
| Diluted Average Shares |
|
1.16
+71.43%
|
0.68
+2729.17%
|
0.02
+160.87%
|
0.01
|
| Diluted NI Availto Com Stockholders |
|
-22.14
-157.21%
|
-8.61
+48.45%
|
-16.70
-2.66%
|
-16.27
|
| Preferred Stock Dividends |
|
—
|
—
|
—
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
9.04
+163.95%
|
3.42
-62.11%
|
9.03
-44.91%
|
16.40
|
| Current Assets |
|
8.68
+348.32%
|
1.94
-72.95%
|
7.15
-36.87%
|
11.33
|
| Cash Cash Equivalents And Short Term Investments |
|
7.96
+1750.70%
|
0.43
-85.29%
|
2.92
-45.47%
|
5.36
|
| Cash And Cash Equivalents |
|
7.96
+1750.70%
|
0.43
-85.29%
|
2.92
-45.47%
|
5.36
|
| Receivables |
|
—
|
0.47
-39.22%
|
0.77
-62.05%
|
2.02
|
| Accounts Receivable |
|
—
|
0.39
-42.79%
|
0.68
-65.53%
|
1.97
|
| Gross Accounts Receivable |
|
—
|
0.39
-42.61%
|
0.68
-65.71%
|
1.99
|
| Allowance For Doubtful Accounts Receivable |
|
—
|
-0.00
+0.00%
|
-0.00
+84.21%
|
-0.02
|
| Other Receivables |
|
—
|
0.08
-10.59%
|
0.09
+97.67%
|
0.04
|
| Inventory |
|
—
|
0.77
+52.69%
|
0.50
-85.42%
|
3.44
|
| Raw Materials |
|
—
|
0.13
-86.53%
|
0.94
-25.92%
|
1.27
|
| Finished Goods |
|
—
|
0.79
-63.47%
|
2.17
-18.59%
|
2.66
|
| Prepaid Assets |
|
0.30
+522.92%
|
0.05
-46.67%
|
0.09
-74.86%
|
0.36
|
| Current Deferred Assets |
|
0.24
|
0.00
|
—
|
—
|
| Assets Held For Sale Current |
|
0.00
-100.00%
|
1.23
-55.85%
|
2.79
|
—
|
| Other Current Assets |
|
0.18
-20.98%
|
0.22
+176.54%
|
0.08
-49.06%
|
0.16
|
| Total Non Current Assets |
|
0.36
-75.81%
|
1.49
-20.85%
|
1.88
-62.90%
|
5.07
|
| Net PPE |
|
0.00
-100.00%
|
0.95
-30.95%
|
1.38
-29.08%
|
1.95
|
| Gross PPE |
|
0.00
-100.00%
|
0.95
-53.55%
|
2.06
-20.06%
|
2.57
|
| Accumulated Depreciation |
|
—
|
-0.69
-2.38%
|
-0.67
-8.20%
|
-0.62
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Buildings And Improvements |
|
0.00
-100.00%
|
0.95
-26.31%
|
1.30
-29.22%
|
1.83
|
| Machinery Furniture Equipment |
|
—
|
0.59
-2.96%
|
0.61
+3.23%
|
0.59
|
| Other Properties |
|
—
|
—
|
—
|
1.83
|
| Leases |
|
—
|
0.15
+0.00%
|
0.15
+0.00%
|
0.15
|
| Goodwill And Other Intangible Assets |
|
—
|
—
|
0.00
-100.00%
|
2.63
|
| Goodwill |
|
—
|
—
|
0.00
-100.00%
|
0.35
|
| Other Intangible Assets |
|
—
|
—
|
—
|
2.28
|
| Other Non Current Assets |
|
0.36
-32.46%
|
0.53
+7.24%
|
0.50
+1.64%
|
0.49
|
| Total Liabilities Net Minority Interest |
|
32.21
+806.84%
|
3.55
-37.90%
|
5.72
-2.14%
|
5.84
|
| Current Liabilities |
|
1.14
-59.83%
|
2.84
-33.54%
|
4.28
+0.49%
|
4.26
|
| Payables And Accrued Expenses |
|
0.65
-5.36%
|
0.69
-38.88%
|
1.13
-43.47%
|
2.00
|
| Payables |
|
0.50
+362.39%
|
0.11
-87.97%
|
0.91
-16.11%
|
1.08
|
| Accounts Payable |
|
0.26
+135.78%
|
0.11
-87.97%
|
0.91
-16.11%
|
1.08
|
| Current Accrued Expenses |
|
0.15
-74.35%
|
0.58
+160.54%
|
0.22
-75.68%
|
0.92
|
| Total Tax Payable |
|
0.25
|
0.00
|
—
|
—
|
| Current Debt And Capital Lease Obligation |
|
0.49
-49.22%
|
0.96
-36.01%
|
1.50
+232.23%
|
0.45
|
| Current Debt |
|
0.07
-88.14%
|
0.56
-50.31%
|
1.14
|
—
|
| Other Current Borrowings |
|
0.07
-88.14%
|
0.56
-50.31%
|
1.14
|
—
|
| Current Capital Lease Obligation |
|
0.42
+6.03%
|
0.40
+8.15%
|
0.37
-18.76%
|
0.45
|
| Current Deferred Liabilities |
|
—
|
0.49
-48.41%
|
0.95
-47.65%
|
1.81
|
| Current Deferred Revenue |
|
—
|
0.49
-48.41%
|
0.95
-47.65%
|
1.81
|
| Other Current Liabilities |
|
—
|
1.19
+70.49%
|
0.70
|
—
|
| Total Non Current Liabilities Net Minority Interest |
|
31.07
+4282.09%
|
0.71
-50.83%
|
1.44
-9.19%
|
1.59
|
| Long Term Debt And Capital Lease Obligation |
|
0.29
-59.52%
|
0.71
-36.01%
|
1.11
-30.23%
|
1.59
|
| Long Term Capital Lease Obligation |
|
0.29
-59.52%
|
0.71
-36.01%
|
1.11
-30.23%
|
1.59
|
| Other Non Current Liabilities |
|
—
|
—
|
0.33
|
—
|
| Preferred Securities Outside Stock Equity |
|
0.35
|
0.00
|
—
|
—
|
| Stockholders Equity |
|
-23.18
-17865.89%
|
-0.13
-103.89%
|
3.31
-68.60%
|
10.55
|
| Common Stock Equity |
|
-23.18
-17071.85%
|
-0.14
-109.90%
|
1.36
-82.01%
|
7.58
|
| Capital Stock |
|
0.26
+1512.50%
|
0.02
-99.18%
|
1.95
-34.75%
|
2.99
|
| Common Stock |
|
0.25
+2420.00%
|
0.01
+233.33%
|
0.00
-85.00%
|
0.02
|
| Preferred Stock |
|
0.01
+0.00%
|
0.01
-99.69%
|
1.95
-34.41%
|
2.97
|
| Share Issued |
|
25.22
+2480.60%
|
0.98
+1422.69%
|
0.06
+451.87%
|
0.01
|
| Ordinary Shares Number |
|
25.22
+2480.60%
|
0.98
+1422.69%
|
0.06
+451.87%
|
0.01
|
| Additional Paid In Capital |
|
186.98
+2.00%
|
183.31
+4.03%
|
176.21
+6.33%
|
165.71
|
| Retained Earnings |
|
-210.41
-14.69%
|
-183.46
-4.92%
|
-174.85
-10.56%
|
-158.15
|
| Total Equity Gross Minority Interest |
|
-23.18
-17865.89%
|
-0.13
-103.89%
|
3.31
-68.60%
|
10.55
|
| Total Capitalization |
|
-23.18
-17865.89%
|
-0.13
-103.89%
|
3.31
-68.60%
|
10.55
|
| Working Capital |
|
7.53
+929.63%
|
-0.91
-131.57%
|
2.88
-59.35%
|
7.08
|
| Invested Capital |
|
-23.11
-5475.58%
|
0.43
-82.81%
|
2.50
-67.01%
|
7.58
|
| Total Debt |
|
0.78
-53.59%
|
1.67
-36.01%
|
2.61
+28.03%
|
2.04
|
| Net Debt |
|
—
|
0.14
|
—
|
—
|
| Capital Lease Obligations |
|
0.71
-35.95%
|
1.11
-25.00%
|
1.48
-27.68%
|
2.04
|
| Net Tangible Assets |
|
-23.18
-17865.89%
|
-0.13
-103.89%
|
3.31
-58.19%
|
7.93
|
| Tangible Book Value |
|
-23.18
-17071.85%
|
-0.14
-109.90%
|
1.36
-72.46%
|
4.95
|
| Derivative Product Liabilities |
|
30.43
|
0.00
-100.00%
|
0.33
|
0.00
|
| Interest Payable |
|
0.06
+56.76%
|
0.04
|
—
|
—
|
| Inventories Adjustments Allowances |
|
—
|
-0.11
+59.85%
|
-0.26
+47.09%
|
-0.50
|
| Line Of Credit |
|
—
|
—
|
—
|
0.00
|
| Other Inventories |
|
—
|
-0.05
+97.95%
|
-2.35
|
—
|
| Preferred Stock Equity |
|
0.01
+0.00%
|
0.01
-99.69%
|
1.95
-34.41%
|
2.97
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-8.43
-12.44%
|
-7.50
-75.94%
|
-4.26
+35.96%
|
-6.65
|
| Cash Flow From Continuing Operating Activities |
|
-8.43
-12.44%
|
-7.50
-75.94%
|
-4.26
+35.96%
|
-6.65
|
| Net Income From Continuing Operations |
|
-33.22
-279.68%
|
-8.75
-52.41%
|
-5.74
+45.88%
|
-10.61
|
| Depreciation Amortization Depletion |
|
0.14
-58.94%
|
0.34
-4.21%
|
0.36
-26.29%
|
0.48
|
| Depreciation |
|
0.14
-58.94%
|
0.34
-4.21%
|
0.36
+196.67%
|
0.12
|
| Amortization Cash Flow |
|
—
|
—
|
0.15
-58.13%
|
0.36
|
| Depreciation And Amortization |
|
0.14
-58.94%
|
0.34
-4.21%
|
0.36
-26.29%
|
0.48
|
| Amortization Of Intangibles |
|
—
|
—
|
0.15
-58.13%
|
0.36
|
| Other Non Cash Items |
|
0.25
-80.02%
|
1.24
-3.50%
|
1.29
+329.23%
|
-0.56
|
| Stock Based Compensation |
|
0.03
-80.41%
|
0.15
-49.14%
|
0.29
+32.27%
|
0.22
|
| Asset Impairment Charge |
|
0.85
|
0.00
-100.00%
|
2.60
-61.86%
|
6.80
|
| Operating Gains Losses |
|
24.49
+175000.00%
|
-0.01
+30.00%
|
-0.02
+99.43%
|
-3.52
|
| Gain Loss On Investment Securities |
|
24.49
+90788.89%
|
-0.03
-35.00%
|
-0.02
+99.43%
|
-3.52
|
| Gain Loss On Sale Of PPE |
|
—
|
—
|
—
|
—
|
| Change In Working Capital |
|
-0.96
-108.42%
|
-0.46
-6.93%
|
-0.43
-181.24%
|
0.53
|
| Change In Receivables |
|
—
|
0.29
-65.60%
|
0.85
+377.38%
|
-0.30
|
| Changes In Account Receivables |
|
—
|
0.29
-65.60%
|
0.85
+377.38%
|
-0.30
|
| Change In Inventory |
|
—
|
-0.27
-267.90%
|
0.16
+174.65%
|
-0.22
|
| Change In Prepaid Assets |
|
-0.45
-584.62%
|
-0.07
-690.91%
|
0.01
-94.95%
|
0.22
|
| Change In Payables And Accrued Expense |
|
-0.04
+35.09%
|
-0.06
+94.94%
|
-1.13
-268.97%
|
0.67
|
| Change In Payable |
|
-0.04
+35.09%
|
-0.06
+94.94%
|
-1.13
-268.97%
|
0.67
|
| Change In Account Payable |
|
-0.04
+35.09%
|
-0.06
+94.94%
|
-1.13
-268.97%
|
0.67
|
| Change In Other Current Assets |
|
-0.09
-403.57%
|
0.03
+566.67%
|
-0.01
+99.58%
|
-1.43
|
| Change In Other Current Liabilities |
|
-0.40
-7.86%
|
-0.37
-15.67%
|
-0.32
-120.00%
|
1.59
|
| Investing Cash Flow |
|
—
|
1.06
+5700.00%
|
-0.02
+83.04%
|
-0.11
|
| Cash Flow From Continuing Investing Activities |
|
—
|
1.06
+5700.00%
|
-0.02
+83.04%
|
-0.11
|
| Net PPE Purchase And Sale |
|
—
|
-0.01
+68.42%
|
-0.02
+83.04%
|
-0.11
|
| Purchase Of PPE |
|
—
|
-0.01
+68.42%
|
-0.02
+83.04%
|
-0.11
|
| Capital Expenditure |
|
—
|
-0.01
+68.42%
|
-0.02
+83.04%
|
-0.11
|
| Net Business Purchase And Sale |
|
—
|
1.07
|
0.00
|
0.00
|
| Purchase Of Business |
|
—
|
—
|
—
|
0.00
|
| Gain Loss On Sale Of Business |
|
—
|
0.86
|
0.00
|
—
|
| Financing Cash Flow |
|
4.62
+207.87%
|
1.50
-21.52%
|
1.91
-58.77%
|
4.63
|
| Cash Flow From Continuing Financing Activities |
|
4.62
+207.87%
|
1.50
-21.52%
|
1.91
-58.77%
|
4.63
|
| Net Issuance Payments Of Debt |
|
-2.50
-67.74%
|
-1.49
-197.71%
|
1.53
+1553.33%
|
-0.10
|
| Issuance Of Debt |
|
0.00
-100.00%
|
0.50
-83.33%
|
3.00
|
0.00
|
| Repayment Of Debt |
|
-2.50
-25.62%
|
-1.99
-35.07%
|
-1.47
-1303.81%
|
-0.10
|
| Long Term Debt Issuance |
|
—
|
—
|
—
|
—
|
| Long Term Debt Payments |
|
-2.50
|
0.00
|
—
|
—
|
| Net Long Term Debt Issuance |
|
-2.50
|
0.00
|
—
|
—
|
| Short Term Debt Issuance |
|
0.00
-100.00%
|
0.50
-83.33%
|
3.00
|
0.00
|
| Short Term Debt Payments |
|
0.00
+100.00%
|
-1.99
-35.07%
|
-1.47
-1303.81%
|
-0.10
|
| Net Short Term Debt Issuance |
|
0.00
+100.00%
|
-1.49
-197.71%
|
1.53
+1553.33%
|
-0.10
|
| Net Common Stock Issuance |
|
2.05
-28.31%
|
2.86
|
0.00
|
0.00
|
| Common Stock Dividend Paid |
|
-4.82
|
0.00
|
—
|
—
|
| Cash Dividends Paid |
|
-4.82
|
0.00
|
—
|
—
|
| Repurchase Of Capital Stock |
|
-0.17
|
0.00
|
—
|
—
|
| Proceeds From Stock Option Exercised |
|
6.27
+2439.68%
|
0.25
-56.28%
|
0.56
-66.82%
|
1.70
|
| Net Other Financing Charges |
|
—
|
-0.12
+36.46%
|
-0.18
|
—
|
| Changes In Cash |
|
7.32
+371.14%
|
-2.70
+1.60%
|
-2.74
-28.60%
|
-2.13
|
| Beginning Cash Position |
|
0.91
-74.85%
|
3.61
-38.32%
|
5.85
-26.73%
|
7.98
|
| End Cash Position |
|
8.22
+806.84%
|
0.91
-73.32%
|
3.40
-41.84%
|
5.85
|
| Free Cash Flow |
|
-8.43
-12.44%
|
-7.50
-75.16%
|
-4.28
+36.74%
|
-6.77
|
| Interest Paid Supplemental Data |
|
—
|
0.15
-22.22%
|
0.19
+1011.76%
|
0.02
|
| Income Tax Paid Supplemental Data |
|
—
|
—
|
0.36
+1395.83%
|
0.02
|
| Common Stock Issuance |
|
2.05
-28.31%
|
2.86
|
0.00
|
0.00
|
| Issuance Of Capital Stock |
|
5.83
+104.16%
|
2.86
|
0.00
-100.00%
|
3.04
|
| Net Preferred Stock Issuance |
|
3.61
|
0.00
|
0.00
-100.00%
|
3.04
|
| Other Cash Adjustment Outside Changein Cash |
|
—
|
0.13
-57.58%
|
0.30
|
—
|
| Preferred Stock Issuance |
|
3.79
|
0.00
|
0.00
-100.00%
|
3.04
|
| Preferred Stock Payments |
|
-0.17
|
0.00
|
—
|
—
|
| Sale Of Business |
|
—
|
1.07
|
0.00
|
—
|
| Cash Flow From Discontinued Operation |
|
—
|
-0.21
+44.77%
|
-0.37
|
—
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-04-02 View
- 42026-04-02 View
- 8-K2026-04-01 View
- 8-K2026-03-23 View
- 10-K2026-03-19 View
- 8-K2026-03-12 View
- 8-K2026-02-20 View
- 8-K2026-02-12 View
- 8-K2026-01-30 View
- 42026-01-29 View
- 8-K2026-01-28 View
- 8-K2026-01-20 View
- 8-K2026-01-16 View
- 10-Q2025-11-07 View
- 42025-11-03 View
- 42025-11-03 View
- 42025-11-03 View
- 8-K2025-10-22 View
- 8-K2025-10-21 View
- 42025-10-20 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|